134 related articles for article (PubMed ID: 11985350)
21. Stereochemical diversity-oriented conformational restriction strategy. Development of potent histamine H3 and/or H4 receptor antagonists with an imidazolylcyclopropane structure.
Watanabe M; Kazuta Y; Hayashi H; Yamada S; Matsuda A; Shuto S
J Med Chem; 2006 Sep; 49(18):5587-96. PubMed ID: 16942032
[TBL] [Abstract][Full Text] [Related]
22. Pharmacological characterization of the novel histamine H3-receptor antagonist N-(3,5-dichlorophenyl)-N'-[[4-(1H-imidazol-4-ylmethyl)phenyl]-methyl]-urea (SCH 79687).
McLeod RL; Rizzo CA; West RE; Aslanian R; McCormick K; Bryant M; Hsieh Y; Korfmacher W; Mingo GG; Varty L; Williams SM; Shih NY; Egan RW; Hey JA
J Pharmacol Exp Ther; 2003 Jun; 305(3):1037-44. PubMed ID: 12649305
[TBL] [Abstract][Full Text] [Related]
23. Role of the histamine system in nefopam-induced antinociception in mice.
Girard P; Pansart Y; Coppé MC; Verniers D; Gillardin JM
Eur J Pharmacol; 2004 Oct; 503(1-3):63-9. PubMed ID: 15496297
[TBL] [Abstract][Full Text] [Related]
24. Histaminergic ligands improve vestibular compensation in the cat: behavioural, neurochemical and molecular evidence.
Tighilet B; Mourre C; Trottier S; Lacour M
Eur J Pharmacol; 2007 Jul; 568(1-3):149-63. PubMed ID: 17573072
[TBL] [Abstract][Full Text] [Related]
25. The histamine H3 receptor as a therapeutic drug target for CNS disorders.
Gemkow MJ; Davenport AJ; Harich S; Ellenbroek BA; Cesura A; Hallett D
Drug Discov Today; 2009 May; 14(9-10):509-15. PubMed ID: 19429511
[TBL] [Abstract][Full Text] [Related]
26. Betahistine increases vestibular blood flow.
Dziadziola JK; Laurikainen EL; Rachel JD; Quirk WS
Otolaryngol Head Neck Surg; 1999 Mar; 120(3):400-5. PubMed ID: 10064646
[TBL] [Abstract][Full Text] [Related]
27. Neuronal histamine H(3) receptors mediate antisecretory effects in the rat isolated gastric fundus.
Adami M; Coruzzi G; Guaita E; Schunack W; Kitbunnadaj R; Timmermann H
Inflamm Res; 2004 Mar; 53 Suppl 1():S25-6. PubMed ID: 15054602
[No Abstract] [Full Text] [Related]
28. Unexpected partial H1-receptor agonism of imidazole-type histamine H3-receptor antagonists lacking a basic side chain.
Sadek B; Elz S; Pertz HH; Stark H; Schunack W
Inflamm Res; 2004 Aug; 53 Suppl 2():S109-15. PubMed ID: 15338060
[TBL] [Abstract][Full Text] [Related]
29. Histaminergic H1 and H2 receptors located within the ventromedial hypothalamus regulate food and water intake in rats.
Magrani J; de Castro e Silva E; Varjão B; Duarte G; Ramos AC; Athanazio R; Barbetta M; Luz P; Fregoneze JB
Pharmacol Biochem Behav; 2004 Sep; 79(1):189-98. PubMed ID: 15388299
[TBL] [Abstract][Full Text] [Related]
30. Histamine-induced ion secretion across rat distal colon: involvement of histamine H1 and H2 receptors.
Schultheiss G; Hennig B; Schunack W; Prinz G; Diener M
Eur J Pharmacol; 2006 Sep; 546(1-3):161-70. PubMed ID: 16919622
[TBL] [Abstract][Full Text] [Related]
31. Nasal allergic response mediated by histamine H3 receptors in murine allergic rhinitis.
Nakaya M; Fukushima Y; Takeuchi N; Kaga K
Laryngoscope; 2005 Oct; 115(10):1778-84. PubMed ID: 16222194
[TBL] [Abstract][Full Text] [Related]
32. Histamine H4 receptor antagonists as potent modulators of mammalian vestibular primary neuron excitability.
Desmadryl G; Gaboyard-Niay S; Brugeaud A; Travo C; Broussy A; Saleur A; Dyhrfjeld-Johnsen J; Wersinger E; Chabbert C
Br J Pharmacol; 2012 Oct; 167(4):905-16. PubMed ID: 22624822
[TBL] [Abstract][Full Text] [Related]
33. Histamine H3 receptors modulate reactive hyperemia in rat gut.
Pawlik WW; Obuchowicz R; Pawlik MW; Sendur R; Biernat J; Brzozowski T; Konturek SJ
J Physiol Pharmacol; 2004 Sep; 55(3):651-61. PubMed ID: 15381834
[TBL] [Abstract][Full Text] [Related]
34. Ameliorating antipsychotic-induced weight gain by betahistine: Mechanisms and clinical implications.
Lian J; Huang XF; Pai N; Deng C
Pharmacol Res; 2016 Apr; 106():51-63. PubMed ID: 26892184
[TBL] [Abstract][Full Text] [Related]
35. Excitatory effect of histamine on neuronal activity of rat globus pallidus by activation of H2 receptors in vitro.
Chen K; Wang JJ; Yung WH; Chan YS; Chow BK
Neurosci Res; 2005 Nov; 53(3):288-97. PubMed ID: 16143415
[TBL] [Abstract][Full Text] [Related]
36. Influence of betahistine repeated administration on a weight gain and selected metabolic parameters in the model of excessive eating in rats.
Mika K; Szafarz M; Sapa J; Kotańska M
Biomed Pharmacother; 2021 Sep; 141():111892. PubMed ID: 34229247
[TBL] [Abstract][Full Text] [Related]
37. Effects of betahistine on the spatiotemporal response properties of vestibulospinal neurons to labyrinthine volleys.
Barresi M; Bruschini L; Li Volsi G; Manzoni D
Eur J Pharmacol; 2005 May; 515(1-3):73-82. PubMed ID: 15878499
[TBL] [Abstract][Full Text] [Related]
38. Histamine and betahistine in the treatment of vertigo: elucidation of mechanisms of action.
Lacour M; Sterkers O
CNS Drugs; 2001; 15(11):853-70. PubMed ID: 11700150
[TBL] [Abstract][Full Text] [Related]
39. Role of central histaminergic system in lorazepam withdrawal syndrome in rats.
Nath C; Gupta MB
Pharmacol Biochem Behav; 2001 Apr; 68(4):777-82. PubMed ID: 11526976
[TBL] [Abstract][Full Text] [Related]
40. Non-imidazole histamine NO-donor H3-antagonists.
Tosco P; Bertinaria M; Di Stilo A; Cena C; Fruttero R; Gasco A
Farmaco; 2005; 60(6-7):507-12. PubMed ID: 15927183
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
